Results 291 to 300 of about 399,504 (355)
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma
IDO expression in stromal cells was upregulated by MM cells via the JAK–STAT1–NF‐κB–IRF1 signaling pathway. JAK inhibitor abolished IDO and IRF1 upregulation. ABSTRACT Stromal cells are an essential component of the tumor microenvironment (TME) in multiple myeloma (MM). Indoleamine 2,3‐dioxygenase 1 (IDO), an enzyme that metabolizes tryptophan (Trp) to
Toru Ebina +18 more
wiley +1 more source
Circular ribonucleic acid 0004104 as a potential biomarker and its relation to Janus kinase 2 in ulcerative colitis [PDF]
Roaa Tarek Elbannan +4 more
openalex +1 more source
Heat shock protein 90 (Hsp90); janus kinase-2 (JAK-2) [PDF]
openaire +1 more source
Well‐being in German patients with vitiligo in genital and visible areas – a pilot study
Summary Background Only a few studies exist on the psychosocial impact of vitiligo in German patients, in particular those affected in genital and visible body areas. Methods This monocentric pilot study aimed to assess well‐being of adult patients with vitiligo and to compare sex, age, and clinical characteristics between patients with and without ...
Janne Ohlenbusch +3 more
wiley +1 more source
Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations. [PDF]
Hammarén HM +5 more
europepmc +1 more source
S1‐Guideline for diagnosis and therapy of necrobiosis lipoidica
Summary Necrobiosis lipoidica (NL) is a rare granulomatous skin disease of unknown etiology that occurs frequently in association with diabetes mellitus and other comorbidities. The predilection site is the lower leg, particularly the pretibial areas. The exact pathogenesis remains unclear.
Cornelia Erfurt‐Berge +6 more
wiley +1 more source
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
J A Johnston +9 more
openalex +2 more sources

